Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis

Journal of Clinical Investigation

Volumn 100, Issue 3, 1997, Pages 503-513

  Bertoni, Roberto ^a   Sidney, John ^b   Fowler, Patricia ^a   Chesnut, Robert W ^b   Chisari, Francis V ^a   Sette, Alessandro ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b CYTEL CORPORATION   (United States)

Author keywords

Chronic hepatitis; Cytotoxic T lymphocytes; Hepatitis B virus; HLA class I supermotifs; Immunotherapy

Indexed keywords

EPITOPE; HEPATITIS VACCINE; HLA ANTIGEN CLASS 1; SYNTHETIC PEPTIDE; VIRUS ANTIGEN;

ACUTE HEPATITIS; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CHRONIC HEPATITIS; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VIRUS HEPATITIS;

EID: 0030811688     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119559     Document Type: Article

References (52)

1. Bertoletti, A., C. Ferrari, F. Fiaccadori, A. Penna, R. Margolskee, H.J. Schlicht, P. Fowler, S. Guilhot, and F.V. Chisari. 1991. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc. Natl. Acad. Sci. USA. 88:10445-10449.
2. Nayersina, R., P. Fowler, S. Guilhot, G. Missale, A. Cerny, H.J. Schlicht, A. Vitiello, R. Chesnut, J.L. Person, A.G. Redeker, et al. 1993. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J. Immunol. 150:4659-4671.
3. Missale, G., A. Redeker, J. Person, P. Fowler, S. Guilhot, H.J. Schlicht, C. Ferrari, and F.V. Chisari. 1993. HLA-A31- and HLA-Aw68 restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J. Exp. Med. 177:751-762.
4. Chisari, F.V., and C. Ferrari. 1995. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13:29-60.
5. Falk, K., O. Rötzschke, S. Stevanovic, G. Jung, and H-G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature (Lond.). 351:290-296.
6. Ruppert, J., J. Sidney, E. Celis, R.T. Kubo, H.M. Grey, and A. Sette. 1993. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell. 74:929-937.
7. Kubo, R.T., A. Sette, H.M. Grey, E. Appella, K. Sakaguchi, N-Z. Zhu, D. Arnott, N. Sherman, J. Shabanowitz, H. Michel, et al. 1994. Definition of specific peptide motifs for four major HLA-A alleles. J. Immunol. 152:3913-3924.
8. Rehermann, B., P. Fowler, J. Sidney, J. Person, A. Redeker, M. Brown, B. Moss, A. Sette, and F.V. Chisari. 1995. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J. Exp. Med. 181:1047-1058.
9. Wentworth, P.A., A. Vitiello, J. Sidney, E. Keogh, R.W. Chesnut, H.M. Grey, and A. Sette. 1996. Differences and similarities in the A2.1-restricted cytotoxic T cell repertoire in humans and human leukocyte antigen-transgenic mice. Eur. J. Immunol. 26:97-101.
10. Sette, A., A. Vitiello, B. Rehermann, P. Fowler, R. Nayersina, W.M. Kast, C.J.M. Melief, C. Oseroff, L. Yuan, J. Ruppert, et al. 1994. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153:5586-5592.
11. Rehermann, B., C. Ferrari, C. Pasquinelli, and F.V. Chisari. 1996. The hepatitis B virus persists for decades after patient's recovery from acute viral hepatitis despite active maintenance of a cytotoxic T lymphocyte response. Nature Med. 2:1104-1108.
12. Rehermann, B., D. Lau, J.H. Hoofnagle, and F.V. Chisari. 1996. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J Clin. Invest. 97:1655-1665.
13. Cerny, A., J.G. McHutchison, C. Pasquinelli, M.A. Brothers, P. Fowler, M. Houghton, and F.V. Chisari. 1994. Hepatitis C virus specific cytotoxic T lymphocyte restricted by HLA-A2 are present in the peripheral blood of patients with chronic hepatitis C. In Viral Hepatitis and Liver Disease. K. Nishioka, H. Suzuki, S. Mishiro, and T. Oda, editors. Springer-Verlag, Tokyo. 190-194.
14. Battegay, M., J. Fikes, A.M. Di Bisceglie, P.A. Wentworth, A. Sette, E. Celis, W.-M. Ching, A. Grakoui, C.M. Rice, K. Kurokohchi, et al. 1995. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J. Virol. 69: 2462-2470.
15. Rehermann, B., K-M. Chang, J.G. McHutchison, R. Kokka, M. Houghton, C.M. Rice, and F.V. Chisari. 1996. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J. Virol. 70:7092-7102.
16. Rehermann, B., K.-M. Chang, J.G. McHutchison, R. Kokka, M. Houghton, and F.V. Chisari. 1996. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J. Clin. Invest. 98:1432-1440.
17. Koshy, R., and G. Inchauspé. 1996. Evaluation of hepatitis C virus protein epitopes for vaccine development. Trends Biotech. 14:364-369.
18. Cease, K.B., and J.A. Berzofsky. 1994. Toward a vaccine for AIDS: the emergence of immunobiology-based vaccine development. Annu. Rev. Immunol. 12:923-989.
19. Vitiello, A., D. Marchesini, J. Furze, L.A. Sherman, and R.W. Chesnut. 1991. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex. J. Exp. Med. 173:1007-1015.
20. Bednarek, M.A., S.Y. Sauma, M.C. Gammon, G. Porter, S. Tamhankar, A.R. Williamson, and H.J. Zweerink. 1991. The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2. J. Immunol. 147:4047-4053.
21. Kast, W.M., R.M.P. Brandt, J. Sidney, J.-W. Drijfhout, R.T. Kubo, H.M. Grey, C.J.M. Melief, and A. Sette. 1994. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. J. Immunol. 152:3904-3912.
22. Celis, E., V. Tsai, C. Crimi, R. DeMars, P.A. Wentworth, R.W. Chesnut, H.M. Grey, A. Sette, and H.M. Serra. 1994. Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc. Natl. Acad. Sci. USA. 91:2105-2109.
23. Wang, R.-F., and S.A. Rosenberg. 1996. Human tumor antigens recognized by T lymphocytes: implications for cancer therapy. J. Leukocyte Biol. 60: 296-309.
24. Molldrem, J., S. Dermime, K. Parker, Y. Zheng Jiang, D. Mavroudis, N. Hensel, P. Fukushima, and A.J. Barrett. 1996. Targeted T-cell therapy for human luekemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells. Blood. 88:2450-2457.
25. del Guercio, M.-F., J. Sidney, G. Hermanson, C. Perez, H.M. Grey, R.T. Kubo, and A. Sette. 1995. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J. Immunol. 154:685-693.
26. Sidney, J., M.-F. del Guercio, S. Southwood, V.H. Engelhard, E. Appella, H-G. Rammensee, K. Falk, O. Rötzschke, M. Takiguchi, R.T. Kubo, et al. 1995. Several HLA alleles share overlapping peptide specificities. J. Immunol. 154:247-259.
27. Sidney, J., H.M. Grey, S. Southwood, E. Celis, P.A. Wentworth, M.-F. del Guercio, R.T. Kubo, R.W. Chesnut, and A. Sette. 1996. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules. Hum. Immunol. 45:79-93.
28. Sidney, J., S. Southwood, M.-F. del Guercio, H.M. Grey, R.W. Chesnut, R.T. Kubo, and A. Sette. 1996. Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules. J. Immunol. 157:3480-3490.
29. Sidney, J., H.M. Grey, R.T. Kubo, and A. Sette. 1996. Practical, biochemical and evolutionary implications of the discovery of HLA class I super-motifs. Immunol. Today. 17:261-266.
30. Panina-Bordignon, P., A. Tan, A. Termijtelen, S. Demotz, G. Corradin, and A. Lanzavecchia. 1989. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur. J. Immunol. 19:2237-2242.
31. Alexander, J., J. Sidney, S. Southwood, J. Ruppert, C. Oseroff, A. Maewal, K. Snoke, H.M. Serra, R.T. Kubo, A. Sette, et al. 1994. Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. Immunity. 1:751-761.
32. Sinigaglia, F., M. Guttinger, J. Kilgus, D.M. Doran, H. Matile, H. Etlinger, A. Trzeciak, D. Gillessen, and J.R.L. Pink. 1988. A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules. Nature (Lond.). 336:778-780.
33. Ferrari, C., A. Bertoletti, A. Penna, A. Cavalli, A. Valli, G. Missale, M. Pilli, P. Fowler, T. Giuberti, F.V. Chisari, et al. 1991. Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen. J. Clin. Invest. 88:214-222.
34. Alexander, J., K. Snoke, J. Ruppert, J. Sidney, M. Wall, S. Southwood, C. Oseroff, T. Arrhenius, F.C.A. Gaeta, S.M. Colón, et al. 1993. Functional consequences of engagement of the T cell receptor by low affinity ligands. J. Immunol. 150:1-7.
35. Snoke, K., J. Alexander, A. Franco, L. Smith, J.V. Brawley, P. Concannon, H.M. Grey, A. Sette, and P. Wentworth. 1993. The inhibition of different T cell lines specific for the same antigen with TCR antagonist peptides. J. Immunol. 151:6815-6821.
36. Krieger, J.I., R.W. Karr, H.M. Grey, W.-Y. Yu, D. O'Sullivan, L. Batovsky, Z.-L. Zheng, S.M. Colón, F.C.A. Gaeta, J. Sidney, et al. 1991. Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognition. J. Immunol. 146:2331-2340.
37. Rothbard, J.B., R.I. Lechler, K. Howland, V. Bal, D.D. Eckels, R. Sekaly, E.O. Long, W.R. Taylor, and J.R. Lamb. 1988. Structural model of HLA-DR1 restricted T cell antigen recognition. Cell. 52:515-523.
38. Oldstone, M.B.A., A. Tishon, R. Geckeler, H. Lewicki, and J.L. Whitton. 1992. A common antiviral cytotoxic T-lymphocyte epitope for diverse major histocompatibility complex haplotypes: Implications for vaccination. Proc. Natl. Acad. Sci. USA. 89:2752-2755.
39. Zinkernagel, R.M., and P.C. Doherty. 1974. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis virus within a syngeneic or semiallogeneic system. Nature (Lond.). 248:701-703.
40. Vitiello, A., G. Ishioka, H.M. Grey, R. Rose, P. Farness, R. LaFond, L. Yuan, F.V. Chisari, J. Furze, R. Bartholomeuz, et al. 1995. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. J. Clin. Invest. 95:341-349.
41. Pasek, M., T. Goto, W. Gilbert, B. Zink, H. Schaller, P. Mackay, G. Leadbetter, and K. Murray. 1979. Hepatitis B virus genes and their expression in E. coli. Nature (Lond.). 282:575.
42. Sette, A., J. Sidney, M.-F. del Guercio, S. Southwood, J. Ruppert, C. Dahlberg, H.M. Grey, and R.T. Kubo. 1994. Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. Mol. Immunol. 31:813-822.
43. Guilhot, S., P. Fowler, G. Portillo, R.F. Margolskee, C. Ferrari, A. Bertoletti, and F.V. Chisari. 1992. Hepatitis B virus (HBV)-specific cytotoxic T cell response in humans: Production of target cells by stable expression of HBV-encoded proteins in immortalized human B-cell lines. J. Virol. 66:2670-2678.
44. Penna, A., F.V. Chisari, A. Bertoletti, G. Missale, P. Fowler, T. Giuberti, F. Fiaccadori, and C. Ferrari. 1991. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J. Exp. Med. 174:1565-1570.
45. Ferrie, R.M., M.J. Schwarz, N.H. Robertson, S. Vaudin, M. Super, G. Malone, and S. Little. 1992. Development, multiplexing, and application of ARMS tests for common mutations in the cFTR gene. Am. J. Hum. Genet. 51:251-262.
46. Zemmour, J., and P. Parham. 1992. HLA class I nucleotide sequences. Tissue Ant. 40:221-228.
47. Fernandez-Vińa, M.A., M. Falco, Y. Sun, and P. Stastny. 1992. DNA typing for HLA class I alleles. I. Subsets of HLA-A2 and of -A28. Hum. Immunol. 33:163-173.
48. Celis, E., D. Ou, and L. Otvos. 1988. Recognition of hepatitis B surface antigen by human T lymphocytes. Proliferative and cytotoxic responses to a major antigenic determinant defined by synthetic peptides. J. Immunol. 140: 1808-1815.
49. Berzofsky, J.A., C.D. Pendleton, M. Clerici, J. Ahlers, D.R. Lucey, S.D. Putney, and G.M. Shearer. 1991. Construction of peptides encompassing multideterminant clusters of HIV envelope to induce in vitro T Cell responses in mice and humans of multiple MHC types. J. Clin. Invest. 88:876-884.
50. Barber, L.D., B. Gillece-Castro, L. Percival, X. Li, C. Clayberger, and P. Parham. 1995. Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypes. Curr. Top. Biol. 5:179-190.
51. O'Sullivan, D., J. Sidney, M.-F. del Guercio, S.M. Colon, and A. Sette. 1991. Truncation analysis of several DR binding epitopes. J. Immunol. 146: 1240-1246.
52. Meadows, L., W. Wang, J.M.M. den Haan, E. Blokland, C. Reinhardus, J.W. Drijfhout, J. Shabanowitz, R. Pierce, A.I. Agulnik, C.E. Bishop, et al. 1997. The HLA-A*0201-Restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity. 6:273-281.